Tinhofer, I., Klinghammer, K., Weichert, W., Knödler, M., Stenzinger, A., Gauler, T., . . . Keilholz, U. (2011). Expression of amphiregulin and EGFRvIII affect outcome of patients with squamous cell carcinoma of the head and neck receiving cetuximab-docetaxel treatment. Clinical cancer research, 17(15), .
Chicago-Zitierstil (17. Ausg.)Tinhofer, Ingeborg, Konrad Klinghammer, Wilko Weichert, Maren Knödler, Albrecht Stenzinger, Thomas Gauler, Volker Budach, und Ulrich Keilholz. "Expression of Amphiregulin and EGFRvIII Affect Outcome of Patients with Squamous Cell Carcinoma of the Head and Neck Receiving Cetuximab-docetaxel Treatment." Clinical Cancer Research 17, no. 15 (2011).
MLA-Zitierstil (9. Ausg.)Tinhofer, Ingeborg, et al. "Expression of Amphiregulin and EGFRvIII Affect Outcome of Patients with Squamous Cell Carcinoma of the Head and Neck Receiving Cetuximab-docetaxel Treatment." Clinical Cancer Research, vol. 17, no. 15, 2011.